Early Rheumatoid Arthritis Tied to Hypertension

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 22, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, Oct. 22, 2024 -- Patients with early rheumatoid arthritis (RA) have a high incidence of prevalent and incident hypertension, according to a study published online in the August issue of Rheumatology: Advances in Practice.

Brook Hadwen, from the University of Western Ontario in London, Canada, and colleagues used data from the Canadian Early Arthritis Cohort to explore the prevalence and incidence of hypertension and baseline factors associated with incident hypertension in early RA (2,052 patients).

The researchers found that the prevalence of hypertension at study enrollment was 26 percent (23 percent in women and 34 percent in men). Prevalent hypertension was associated with older age, diabetes, and hyperlipidemia in both sexes. In women, hypertension was associated with being overweight or with high alcohol consumption. One quarter (24 percent) of the RA patients did not have hypertension at enrollment but developed hypertension during the median follow-up period of five years. Incident hypertension was significantly associated with the baseline factors of older age, being overweight, excess alcohol consumption, and having hyperlipidemia. There were no significant associations between RA-associated disease factors and treatments with prevalent or incident hypertension.

"Weight loss and lifestyle modifications such as changes in diet, exercise, and limiting alcohol intake may reduce the risk of high blood pressure and prevent heart disease," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-23 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords